News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
748,785 Results
Type
Article (44243)
Company Profile (467)
Press Release (704060)
Multimedia
Podcasts (145)
Webinars (23)
Section
Business (209536)
Career Advice (2049)
Deals (36227)
Drug Delivery (140)
Drug Development (84157)
Employer Resources (174)
FDA (16811)
Job Trends (15231)
News (354714)
Policy (33306)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (4)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (6)
Academia (2689)
Accelerated approval (54)
Adcomms (31)
Allergies (179)
Alliances (51117)
ALS (223)
Alzheimer's disease (1869)
Antibody-drug conjugate (ADC) (503)
Approvals (17185)
Artificial intelligence (715)
Autoimmune disease (323)
Automation (57)
Bankruptcy (374)
Best Places to Work (11840)
BIOSECURE Act (20)
Biosimilars (228)
Biotechnology (325)
Bladder cancer (204)
Brain cancer (77)
Breast cancer (789)
Cancer (6139)
Cardiovascular disease (505)
Career advice (1743)
Career pathing (45)
CAR-T (349)
CDC (59)
Celiac Disease (3)
Cell therapy (962)
Cervical cancer (49)
Clinical research (72941)
Collaboration (2209)
Company closure (5)
Compensation (1441)
Complete response letters (91)
COVID-19 (2811)
CRISPR (118)
C-suite (1205)
Cystic fibrosis (163)
Data (8272)
Decentralized trials (3)
Denatured (46)
Depression (176)
Dermatology (93)
Diabetes (607)
Diagnostics (7026)
Digital health (57)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (352)
Drug pricing (213)
Drug shortages (32)
Duchenne muscular dystrophy (308)
Earnings (93469)
Editorial (70)
Employer branding (21)
Employer resources (153)
Events (123760)
Executive appointments (1130)
FDA (20661)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (36)
Funding (1827)
Gene editing (257)
Generative AI (58)
Gene therapy (791)
GLP-1 (1113)
Government (4841)
Grass and pollen (6)
Guidances (412)
Healthcare (19426)
HIV (84)
Huntington's disease (58)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (105)
Immunology and inflammation (323)
Immuno-oncology (105)
Indications (198)
Infectious disease (3168)
Inflammatory bowel disease (229)
Inflation Reduction Act (17)
Influenza (140)
Intellectual property (303)
Interviews (319)
IPO (16959)
IRA (53)
Job creations (3718)
Job search strategy (1443)
JPM (67)
Kidney cancer (19)
Labor market (104)
Layoffs (600)
Leadership (42)
Legal (8032)
Liver cancer (104)
Longevity (34)
Lung cancer (810)
Lymphoma (445)
Machine learning (61)
Management (59)
Manufacturing (1095)
MASH (208)
Medical device (14103)
Medtech (14236)
Mergers & acquisitions (20531)
Metabolic disorders (1601)
mRNA (240)
Multiple sclerosis (197)
NASH (20)
Neurodegenerative disease (459)
Neuropsychiatric disorders (115)
Neuroscience (3489)
Neurotech (1)
NextGen: Class of 2026 (6773)
Non-profit (4607)
Now hiring (79)
Obesity (756)
Opinion (315)
Ovarian cancer (233)
Pain (266)
Pancreatic cancer (320)
Parkinson's disease (392)
Partnered (34)
Patents (613)
Patient recruitment (712)
Peanut (63)
People (61139)
Pharmaceutical (79)
Pharmacy benefit managers (34)
Phase 1 (22944)
Phase 2 (32193)
Phase 3 (23756)
Pipeline (9190)
Policy (338)
Postmarket research (2607)
Preclinical (9847)
Press Release (67)
Prostate cancer (323)
Psychedelics (64)
Radiopharmaceuticals (356)
Rare diseases (1166)
Real estate (6083)
Recruiting (71)
Regulatory (26056)
Reports (56)
Research institute (2516)
Resumes & cover letters (355)
Rett syndrome (39)
RNA editing (27)
RSV (88)
Schizophrenia (187)
Series A (309)
Series B (227)
Service/supplier (11)
Sickle cell disease (121)
Special edition (29)
Spinal muscular atrophy (171)
Sponsored (49)
Startups (3836)
State (2)
Stomach cancer (19)
Supply chain (132)
Tariffs (88)
The Weekly (96)
Vaccines (1145)
Venture capital (120)
Weight loss (491)
Women's health (132)
Worklife (21)
Date
Today (2)
Last 7 days (622)
Last 30 days (3263)
Last 365 days (30915)
2026 (14039)
2025 (31060)
2024 (36286)
2023 (41013)
2022 (52276)
2021 (56759)
2020 (54917)
2019 (47414)
2018 (35693)
2017 (33022)
2016 (32345)
2015 (38395)
2014 (32185)
2013 (27109)
2012 (29220)
2011 (29863)
2010 (27992)
Location
Africa (759)
Alabama (99)
Alaska (7)
Arizona (361)
Arkansas (16)
Asia (41252)
Australia (6874)
California (13780)
Canada (3858)
China (1437)
Colorado (588)
Connecticut (608)
Delaware (418)
Europe (90800)
Florida (2036)
Georgia (440)
Hawaii (3)
Idaho (63)
Illinois (1103)
India (93)
Indiana (617)
Iowa (25)
Japan (563)
Kansas (135)
Kentucky (52)
Louisiana (45)
Maine (76)
Maryland (1640)
Massachusetts (9953)
Michigan (374)
Minnesota (745)
Mississippi (6)
Missouri (147)
Montana (35)
Nebraska (29)
Nevada (145)
New Hampshire (89)
New Jersey (3620)
New Mexico (32)
New York (3580)
North Carolina (1804)
North Dakota (10)
Northern California (6918)
Ohio (409)
Oklahoma (23)
Oregon (44)
Pennsylvania (2742)
Puerto Rico (29)
Rhode Island (51)
South America (1126)
South Carolina (86)
South Dakota (2)
Southern California (5414)
Tennessee (216)
Texas (2185)
United States (48689)
Utah (408)
Vermont (1)
Virginia (332)
Washington D.C. (82)
Washington State (1126)
West Virginia (4)
Wisconsin (135)
Wyoming (2)
748,785 Results for "halozyme therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Halozyme’s $900M Elektrofi Buyout Brings Two Big Pharma Partners Together
Both Halozyme and Elektrofi have partnered with several Big Pharma companies to provide drug delivery technologies.
October 2, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Metagenomi Therapeutics, Inc. to Present at the 2026 Jefferies Global Healthcare Conference
May 28, 2026
·
1 min read
Press Releases
Halozyme and Skye Bioscience Announce Global Collaboration and License Agreement to Evaluate Nimacimab Co-Formulated with ENHANZE® for Obesity
January 5, 2026
·
6 min read
Press Releases
Rakovina Therapeutics Inc. Announces 2025 Financial Results and Provides Corporate Update
April 30, 2026
·
10 min read
Press Releases
enGene Announces Name Change to enGene Therapeutics Inc.
April 7, 2026
·
8 min read
Press Releases
Medtronic announces intent to acquire SPR Therapeutics, Inc., expanding care options for people living with chronic pain
May 20, 2026
·
4 min read
Press Releases
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Responds to BBB Challenge with Next-Gen Drug-Delivery Platform
May 14, 2026
·
6 min read
Press Releases
Scilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings Limited
May 5, 2026
·
8 min read
Press Releases
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Real-World Example of Scientific Advancement Influence on Evaluation
April 23, 2026
·
6 min read
Patents
Merck’s Injectable Keytruda Plans Create Legal Dispute With Halozyme:
WSJ
The new formulation of Keytruda, currently under FDA review, is sparking conflict with Halozyme, which makes enzymes that convert intravenous drugs into injectable versions.
March 5, 2025
·
1 min read
·
Dan Samorodnitsky
1 of 74,879
Next
